---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-068098"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2025-07-15T23:59:59+00:00"
generated_at: "2026-05-18T06:28:26.068612+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Carisma receives Nasdaq delisting notice for bid price non-compliance; schedules Aug 5 reverse split vote

## Summary
- Nasdaq notified Carisma on July 9, 2025 that failure to regain bid price compliance is an additional delisting basis.
- Listing transferred to Nasdaq Capital Market on June 12, 2025 with exception through Oct 7, 2025 to show compliance.
- Special meeting set for Aug 5, 2025 to approve reverse stock split (1:10 to 1:50) to increase bid price.
- No assurance reverse split will achieve compliance or Panel terms will be met by Oct 7, 2025.

## SEC filing metadata
- accession: 0001104659-25-068098
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2025-07-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465925068098/0001104659-25-068098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465925068098/tm2521012d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-068098
- JSON: https://secwatch.observer/filing/0001104659-25-068098.json
- Plain text: https://secwatch.observer/filing/0001104659-25-068098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.